Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness of Recombinant Versus Standard Dose Quadrivalent Influenza Vaccine in U.S. Nursing Homes

NCT03965195 is registered in ClinicalTrials.gov with Insight Therapeutics, LLC as lead sponsor.

NCT NCT03965195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03965195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness of Recombinant Versus Standard Dose Quadrivalent Influenza Vaccine in U.S. Nursing Homes
Lead sponsor
Insight Therapeutics, LLC
Phase
Phase 4
Overall status
Unknown status
Start date
July 20, 2019
Completion date
December 31, 2023
Enrollment
1,989 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, influenza -like illness, influenza, human